Effect of celiprolol on prevention of cardiovascular events in vascular Ehlers-Danlos syndrome: a prospective randomised, open, blinded-endpoints trial
- Author
- ONG, Kim-Thanh1 2 3 ; PERDU, Jérôme1 ; HULOT, Jean-Sebastien1 11 ; DE PAEPE, Anne2 3 4 ; PLAUCHU, Henri1 12 ; JEUNEMAITRE, Xavier1 13 2 3 ; LAURENT, Stéphane1 ; BOUTOUYRIE, Pierre1 2 3 ; DE BACKER, Julie4 ; BOZEC, Erwan1 ; COLLIGNON, Patrick1 5 ; EMMERICH, Joseph1 2 3 6 ; FAURET, Anne-Laure1 7 ; FIESSINGER, Jean-Noël1 8 ; GERMAIN, Dominique P1 8 ; GEORGESCO, Gabriella10 9
[1] Assistance Publique, Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Paris, France
[2] INSERM U970, Paris, France
[3] Université Paris, Descartes, Paris, France
[4] Centre for Medical Genetics, Ghent University Hospital, Belgium
[5] Assistance Publique, Hôpitaux de Marseille, Marseille, France
[6] INSERM U765, Paris, France
[7] Assistance Publique, Hôpitaux de Paris, Hôpital Raymond Poincaré, Garches, France
[8] Université de Versailles Saint-Quentin-en-Yvelines, France
[9] Centre Hospitalier Régional et Universitaire de Tours, Hôpital Trousseau, Paris, France
[10] Assistance Publique, Hôpitaux de Paris, Hôpital Pitié Salpêtrière, Paris, France
[11] INSERM U621, Paris, France
[12] Hospices Civils de Lyon, Lyon, France
[13] Université Claude Bernard Lyon 1, Lyon, France - Source
Lancet (British edition). 2010, Vol 376, Num 9751, pp 1476-1484, 9 p ; ref : 36 ref
- CODEN
- LANCAO
- ISSN
- 0140-6736
- Scientific domain
- General medicine general surgery
- Publisher
- Elsevier, Kidlington
- Publication country
- United Kingdom
- Document type
- Article
- Language
- English
- Keyword (fr)
- Antihypertenseur Céliprolol Essai clinique Médecine Pathologie de l'appareil circulatoire Prospective Prévention Randomisation Syndrome d'Ehlers-Danlos Vaisseau sanguin Vasodilatateur Antagoniste Appareil circulatoire Bloquant β-adrénergique Maladie de système Maladie héréditaire Pathologie de la peau Pathologie du système ostéoarticulaire Pathologie du tissu élastique Récepteur β-adrénergique
- Keyword (en)
- Antihypertensive agent Celiprolol Clinical trial Medicine Cardiovascular disease Prospective Prevention Randomization Ehlers-Danlos syndrome Blood vessel Vasodilator agent Antagonist Circulatory system Beta blocking agent Systemic disease Genetic disease Skin disease Diseases of the osteoarticular system Elastic tissue disease β-Adrenergic receptor
- Keyword (es)
- Antihipertensivo Celiprolol Ensayo clínico Medicina Aparato circulatorio patología Prospectiva Prevención Aleatorización Piel elástica Vaso sanguíneo Vasodilatador Antagonista Aparato circulatorio Bloqueador β-adrenérgico Enfermedad sistémica Enfermedad hereditaria Piel patología Sistema osteoarticular patología Tejido elástico patología Receptor β-adrenérgico
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B07 Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B30 Public health. Hygiene-occupational medicine / 002B30A Public health. Hygiene / 002B30A03 Prevention and actions
- Discipline
- Generalities in medical sciences Public health. Hygiene-occupational medicine Sarcoidosis. Granulomatosis of undetermined origin. Connective tissue diseases. Vasculitides
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 23371045
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1016/S0140-6736(10)60960-9 
https://dx.doi.org/10.1016/S0140-6736(10)60960-9
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/S0140-6736(10)60960-9\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:151:\"Effect of celiprolol on prevention of cardiovascular events in vascular Ehlers-Danlos syndrome: a prospective randomised, open, blinded-endpoints trial\";s:9:\"\u0000*\u0000jtitle\";s:24:\"Lancet (British edition)\";s:9:\"\u0000*\u0000stitle\";s:16:\"Lancet (Br. ed.)\";s:7:\"\u0000*\u0000date\";s:4:\"2010\";s:9:\"\u0000*\u0000volume\";s:3:\"376\";s:8:\"\u0000*\u0000issue\";s:4:\"9751\";s:8:\"\u0000*\u0000spage\";s:4:\"1476\";s:8:\"\u0000*\u0000epage\";s:4:\"1484\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0140-6736\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:3:\"ONG\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Kim-Thanh\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:15:{i:0;s:15:\"PERDU, J\u00e9r\u00f4me\";i:1;s:21:\"HULOT, Jean-Sebastien\";i:2;s:14:\"DE PAEPE, Anne\";i:3;s:14:\"PLAUCHU, Henri\";i:4;s:19:\"JEUNEMAITRE, Xavier\";i:5;s:18:\"LAURENT, St\u00e9phane\";i:6;s:18:\"BOUTOUYRIE, Pierre\";i:7;s:16:\"DE BACKER, Julie\";i:8;s:12:\"BOZEC, Erwan\";i:9;s:18:\"COLLIGNON, Patrick\";i:10;s:16:\"EMMERICH, Joseph\";i:11;s:18:\"FAURET, Anne-Laure\";i:12;s:22:\"FIESSINGER, Jean-No\u00ebl\";i:13;s:20:\"GERMAIN, Dominique P\";i:14;s:20:\"GEORGESCO, Gabriella\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"LANCAO\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:151:\"Effect of celiprolol on prevention of cardiovascular events in vascular Ehlers-Danlos syndrome: a prospective randomised, open, blinded-endpoints trial\";s:8:\"\u0000*\u0000place\";s:10:\"Kidlington\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/S0140-6736(10)60960-9\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:151:\"Effect of celiprolol on prevention of cardiovascular events in vascular Ehlers-Danlos syndrome: a prospective randomised, open, blinded-endpoints trial\";s:9:\"\u0000*\u0000jtitle\";s:24:\"Lancet (British edition)\";s:9:\"\u0000*\u0000stitle\";s:16:\"Lancet (Br. ed.)\";s:7:\"\u0000*\u0000date\";s:4:\"2010\";s:9:\"\u0000*\u0000volume\";s:3:\"376\";s:8:\"\u0000*\u0000issue\";s:4:\"9751\";s:8:\"\u0000*\u0000spage\";s:4:\"1476\";s:8:\"\u0000*\u0000epage\";s:4:\"1484\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0140-6736\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:3:\"ONG\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Kim-Thanh\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:15:{i:0;s:15:\"PERDU, J\u00e9r\u00f4me\";i:1;s:21:\"HULOT, Jean-Sebastien\";i:2;s:14:\"DE PAEPE, Anne\";i:3;s:14:\"PLAUCHU, Henri\";i:4;s:19:\"JEUNEMAITRE, Xavier\";i:5;s:18:\"LAURENT, St\u00e9phane\";i:6;s:18:\"BOUTOUYRIE, Pierre\";i:7;s:16:\"DE BACKER, Julie\";i:8;s:12:\"BOZEC, Erwan\";i:9;s:18:\"COLLIGNON, Patrick\";i:10;s:16:\"EMMERICH, Joseph\";i:11;s:18:\"FAURET, Anne-Laure\";i:12;s:22:\"FIESSINGER, Jean-No\u00ebl\";i:13;s:20:\"GERMAIN, Dominique P\";i:14;s:20:\"GEORGESCO, Gabriella\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"LANCAO\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:151:\"Effect of celiprolol on prevention of cardiovascular events in vascular Ehlers-Danlos syndrome: a prospective randomised, open, blinded-endpoints trial\";s:8:\"\u0000*\u0000place\";s:10:\"Kidlington\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/S0140-6736(10)60960-9\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/S0140-6736(10)60960-9\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:151:\"Effect of celiprolol on prevention of cardiovascular events in vascular Ehlers-Danlos syndrome: a prospective randomised, open, blinded-endpoints trial\";s:9:\"\u0000*\u0000jtitle\";s:24:\"Lancet (British edition)\";s:9:\"\u0000*\u0000stitle\";s:16:\"Lancet (Br. ed.)\";s:7:\"\u0000*\u0000date\";s:4:\"2010\";s:9:\"\u0000*\u0000volume\";s:3:\"376\";s:8:\"\u0000*\u0000issue\";s:4:\"9751\";s:8:\"\u0000*\u0000spage\";s:4:\"1476\";s:8:\"\u0000*\u0000epage\";s:4:\"1484\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0140-6736\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:3:\"ONG\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Kim-Thanh\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:15:{i:0;s:15:\"PERDU, J\u00e9r\u00f4me\";i:1;s:21:\"HULOT, Jean-Sebastien\";i:2;s:14:\"DE PAEPE, Anne\";i:3;s:14:\"PLAUCHU, Henri\";i:4;s:19:\"JEUNEMAITRE, Xavier\";i:5;s:18:\"LAURENT, St\u00e9phane\";i:6;s:18:\"BOUTOUYRIE, Pierre\";i:7;s:16:\"DE BACKER, Julie\";i:8;s:12:\"BOZEC, Erwan\";i:9;s:18:\"COLLIGNON, Patrick\";i:10;s:16:\"EMMERICH, Joseph\";i:11;s:18:\"FAURET, Anne-Laure\";i:12;s:22:\"FIESSINGER, Jean-No\u00ebl\";i:13;s:20:\"GERMAIN, Dominique P\";i:14;s:20:\"GEORGESCO, Gabriella\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"LANCAO\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:151:\"Effect of celiprolol on prevention of cardiovascular events in vascular Ehlers-Danlos syndrome: a prospective randomised, open, blinded-endpoints trial\";s:8:\"\u0000*\u0000place\";s:10:\"Kidlington\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/S0140-6736(10)60960-9\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:151:\"Effect of celiprolol on prevention of cardiovascular events in vascular Ehlers-Danlos syndrome: a prospective randomised, open, blinded-endpoints trial\";s:9:\"\u0000*\u0000jtitle\";s:24:\"Lancet (British edition)\";s:9:\"\u0000*\u0000stitle\";s:16:\"Lancet (Br. ed.)\";s:7:\"\u0000*\u0000date\";s:4:\"2010\";s:9:\"\u0000*\u0000volume\";s:3:\"376\";s:8:\"\u0000*\u0000issue\";s:4:\"9751\";s:8:\"\u0000*\u0000spage\";s:4:\"1476\";s:8:\"\u0000*\u0000epage\";s:4:\"1484\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0140-6736\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:3:\"ONG\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Kim-Thanh\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:15:{i:0;s:15:\"PERDU, J\u00e9r\u00f4me\";i:1;s:21:\"HULOT, Jean-Sebastien\";i:2;s:14:\"DE PAEPE, Anne\";i:3;s:14:\"PLAUCHU, Henri\";i:4;s:19:\"JEUNEMAITRE, Xavier\";i:5;s:18:\"LAURENT, St\u00e9phane\";i:6;s:18:\"BOUTOUYRIE, Pierre\";i:7;s:16:\"DE BACKER, Julie\";i:8;s:12:\"BOZEC, Erwan\";i:9;s:18:\"COLLIGNON, Patrick\";i:10;s:16:\"EMMERICH, Joseph\";i:11;s:18:\"FAURET, Anne-Laure\";i:12;s:22:\"FIESSINGER, Jean-No\u00ebl\";i:13;s:20:\"GERMAIN, Dominique P\";i:14;s:20:\"GEORGESCO, Gabriella\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"LANCAO\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:151:\"Effect of celiprolol on prevention of cardiovascular events in vascular Ehlers-Danlos syndrome: a prospective randomised, open, blinded-endpoints trial\";s:8:\"\u0000*\u0000place\";s:10:\"Kidlington\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/S0140-6736(10)60960-9\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:151:\"Effect of celiprolol on prevention of cardiovascular events in vascular Ehlers-Danlos syndrome: a prospective randomised, open, blinded-endpoints trial\";s:9:\"\u0000*\u0000jtitle\";s:24:\"Lancet (British edition)\";s:9:\"\u0000*\u0000stitle\";s:16:\"Lancet (Br. ed.)\";s:7:\"\u0000*\u0000date\";s:4:\"2010\";s:9:\"\u0000*\u0000volume\";s:3:\"376\";s:8:\"\u0000*\u0000issue\";s:4:\"9751\";s:8:\"\u0000*\u0000spage\";s:4:\"1476\";s:8:\"\u0000*\u0000epage\";s:4:\"1484\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0140-6736\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:3:\"ONG\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Kim-Thanh\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:15:{i:0;s:15:\"PERDU, J\u00e9r\u00f4me\";i:1;s:21:\"HULOT, Jean-Sebastien\";i:2;s:14:\"DE PAEPE, Anne\";i:3;s:14:\"PLAUCHU, Henri\";i:4;s:19:\"JEUNEMAITRE, Xavier\";i:5;s:18:\"LAURENT, St\u00e9phane\";i:6;s:18:\"BOUTOUYRIE, Pierre\";i:7;s:16:\"DE BACKER, Julie\";i:8;s:12:\"BOZEC, Erwan\";i:9;s:18:\"COLLIGNON, Patrick\";i:10;s:16:\"EMMERICH, Joseph\";i:11;s:18:\"FAURET, Anne-Laure\";i:12;s:22:\"FIESSINGER, Jean-No\u00ebl\";i:13;s:20:\"GERMAIN, Dominique P\";i:14;s:20:\"GEORGESCO, Gabriella\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"LANCAO\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:151:\"Effect of celiprolol on prevention of cardiovascular events in vascular Ehlers-Danlos syndrome: a prospective randomised, open, blinded-endpoints trial\";s:8:\"\u0000*\u0000place\";s:10:\"Kidlington\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
